Closing the gender gap in biotech – a Q&A with Professor Victoria Hutter, CSO of ImmuONE
Gender equality in the biotech industry has come a long way in recent years. In the UK, the US and Europe, women now make…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse quis nibh eget urna placerat dictum in ac mauris. Etiam pellentesque tristique pretium.
Gender equality in the biotech industry has come a long way in recent years. In the UK, the US and Europe, women now make…
New innovations, new research, new teammates, a new lab – and soon, a new year! Before we turn our attention to 2024, let’s take…
ImmuONE made a significant stride on November 8th by hosting its first-ever webinar, ‘unveiling insights into the next generation of tools for inhalation risk…
In our most recent coffee chat, we caught up with Jo Kelsall, our new lead commercial scientist. Jo shared with us her unique career…
Dr Abigail Martin and Professor Victoria Hutter have secured backing from the MEIF Proof of Concept & Early Stage Fund, which is managed by…
In our latest coffee chat, we had the pleasure of sitting down with Rhamiya Mahendran, an Application Scientist at ImmuONE…
Inhaled substances are primarily tested on rats for toxicity, but key differences between rat and human lungs suggest it’s time to look towards alternative…
morph_ONE is a reproducible, mechanistic-driven assay that reveals how inhaled substances affect more than a dozen morphological and biochemical features of alveolar macrophages. The…
Further development of the ImmuPHAGE™ model has been the focus of Amjad’s work during his…